Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation

American Journal of Nephrology

Volumn 35, Issue 4, 2012, Pages 365-371

  Naina, Harris V K ^a   Harris, Samar ^b   Dispenzieri, Angela ^c   Cosio, Fernando G ^c   Habermann, Thomas M ^c   Stegall, Mark D ^c   Dean, Patrick G ^c   Prieto, Mikel ^c   Kyle, Robert A ^c   Rajkumar, S Vincent ^c   Leung, Nelson ^c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c MAYO CLINIC   (United States)

Author keywords

End stage renal disease; Kidney transplantation; Monoclonal gammopathy; Paraproteinemia; Posttransplant lymphoproliferative disorder

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MYCOPHENOLIC ACID; OKT 3; PREDNISONE; TACROLIMUS;

ADULT; AGED; ARTICLE; DYSPROTEINEMIA; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; PROTEIN ELECTROPHORESIS; UNITED STATES;

ADULT; AGED; ANTIGENS, VIRAL; DISEASE PROGRESSION; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN M; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE; MULTIPLE MYELOMA; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84859153189     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000337482     Document Type: Article

References (26)

1. Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, Dispenzieri A, Katzmann JA, Melton LJ 3rd: Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 2006; 354: 1362-1369.
2. Leung N, Lager DJ, Gertz MA, Wilson K, Kanakiriya S, Fervenza FC: Long-term outcome of renal transplantation in light-chain deposition disease. Am J Kidney Dis 2004; 43: 147-153. (Pubitemid 38049446)
3. Blade J, Dimopoulos M, Rosinol L, Rajkumar SV, Kyle RA: Smoldering (asymptomatic) multiple myeloma: current diagnostic criteria, new predictors of outcome, and followup recommendations. J Clin Oncol 2010; 28: 690-697.
4. Kyle RA, Remstein ED, Therneau TM, Dispenzieri A, Kurtin PJ, Hodnefield JM, Larson DR, Plevak MF, Jelinek DF, Fonseca R, Melton LJ 3rd, Rajkumar SV: Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma. N Engl J Med 2007; 356: 2582-2590. (Pubitemid 46961003)
5. Kyle RA, Durie BG, Rajkumar SV, Landgren O, Blade J, Merlini G, Kroger N, Einsele H, Vesole DH, Dimopoulos M, San Miguel J, Avet-Loiseau H, Hajek R, Chen WM, Anderson KC, Ludwig H, Sonneveld P, Pavlovsky S, Palumbo A, Richardson PG, Barlogie B, Greipp P, Vescio R, Turesson I, Westin J, Boccadoro M: Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia 2010; 24: 1121-1127.
6. Rajkumar SV, Larson D, Kyle RA: Diagnosis of smoldering multiple myeloma. N Engl J Med 2011; 365: 474-475.
7. Rostaing L, Modesto A, Abbal M, Durand D: Long-term follow-up of monoclonal gammopathy of undetermined significance in transplant patients. Am J Nephrol 1994; 14: 187-191. (Pubitemid 24257957)
8. Badley AD, Portela DF, Patel R, Kyle RA, Habermann TM, Strickler JG, Ilstrup DM, Wiesner RH, de Groen P, Walker RC, Paya CV: Development of monoclonal gammopathy precedes the development of Epstein- Barr virus-induced posttransplant lymphoproliferative disorder. Liver Transpl Surg 1996; 2: 375-382. (Pubitemid 26303927)
9. Czarnecki PG, Lager DJ, Leung N, Dispenzieri A, Cosio FG, Fervenza FC: Long-term outcome of kidney transplantation in patients with fibrillary glomerulonephritis or monoclonal gammopathy with fibrillary deposits. Kidney Int 2009; 75: 420-427.
10. Lorenz EC, Sethi S, Leung N, Dispenzieri A, Fervenza FC, Cosio FG: Recurrent membranoproliferative glomerulonephritis after kidney transplantation. Kidney Int 2010; 77: 721-728.
11. Swerdlow SH CE, Harris NL, et al. (ed): Posttransplant lymphoproliferative disorders; in WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues. Lyon, IARC Press, 2008, pp 343-349.
12. Fogo A, Qureshi N, Horn RG: Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy. Am J Kidney Dis 1993; 22: 367-377. (Pubitemid 23263610)
13. Radl J, Valentijn RM, Haaijman JJ, Paul LC: Monoclonal gammapathies in patients undergoing immunosuppressive treatment after renal transplantation. Clin Immunol Immunopathol 1985; 37: 98-102. (Pubitemid 16242008)
14. Passweg J, Thiel G, Bock HA: Monoclonal gammopathy after intense induction immunosuppression in renal transplant patients. Nephrol Dial Transplant 1996; 11: 2461-2465. (Pubitemid 27033781)
15. Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton LJ 3rd: A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 2002; 346: 564-569. (Pubitemid 34438817)
16. Rajkumar SV, Kyle RA, Therneau TM, Melton LJ 3rd, Bradwell AR, Clark RJ, Larson DR, Plevak MF, Dispenzieri A, Katzmann JA: Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood 2005; 106: 812-817. (Pubitemid 41076419)
17. Passweg J, Bock HA, Tichelli A, Thiel G: 'Transient multiple myeloma' after intense immunosuppression in a renal transplant patient. Nephrol Dial Transplant 1993; 8: 1393-1394. (Pubitemid 24038079)
18. Dysseleer A, Michaux L, Cosyns JP, Goffin E, Hermans C, Pirson Y: Benign monoclonal gammopathy turning to al amyloidosis after kidney transplantation. Am J Kidney Dis 1999; 34: 166-169. (Pubitemid 29318813)
19. Babel N, Schwarzmann F, Pruss A, Volk HD, Reinke P: Monoclonal gammopathy of undetermined significance (MGUS) is associated with an increased frequency of Epstein-Barr virus (EBV) latently infected B lymphocytes in long-term renal transplant patients. Transplant Proc 2004; 36: 2679-2682. (Pubitemid 40036810)
20. Caillard S, Agodoa LY, Bohen EM, Abbott KC: Myeloma, Hodgkin disease, and lymphoid leukemia after renal transplantation: characteristics, risk factors and prognosis. Transplantation 2006; 81: 888-895.
21. Nelson BP, Nalesnik MA, Bahler DW, Locker J, Fung JJ, Swerdlow SH: Epstein-Barr virusnegative post-transplant lymphoproliferative disorders: a distinct entity? Am J Surg Pathol 2000; 24: 375-385. (Pubitemid 30127473)
22. Gentile TC, Hadlock KG, Uner AH, Delal B, Squiers E, Crowley S, Woodman RC, Foung SK, Poiesz BJ, Loughran TP Jr: Large granular lymphocyte leukaemia occurring after renal transplantation. Br J Haematol 1998; 101: 507-512. (Pubitemid 28266946)
23. Caillard S, Dharnidharka V, Agodoa L, Bohen E, Abbott K: Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation 2005; 80: 1233-1243. (Pubitemid 41746802)
24. Saadat A, Einollahi B, Ahmadzad-Asl MA, Moradi M, Nafar M, Pourfarziani V, Firoozan A, Porrezagholi F, Davoudi F: Posttransplantation lymphoproliferative disorders in renal transplant recipients: report of over 20 years of experience. Transplant Proc 2007; 39: 1071-1073. (Pubitemid 46764891)
25. Soler MJ, Puig JM, Mir M, Parrilla J, Pedro C, Salar A, Serrano S, Lloveras J: Posttransplant lymphoproliferative disease: treatment and outcome in renal transplant recipients. Transplant Proc 2003; 35: 1709-1713. (Pubitemid 37093683)
26. Katzmann JA, Kyle RA, Benson J, Larson DR, Snyder MR, Lust JA, Rajkumar SV, Dispenzieri A: Screening panels for detection of monoclonal gammopathies. Clin Chem 2009; 55: 1517-1522.